Hi @Davisite,
congratulations to the Race team on some more great results! I have a couple of questions on the 2 charts.
Can you expand on why in Figure 2 the data was divided into those three "buckets"? Is there any particular significance to the 2-fold improvement value?
Also, I didn't see any mention of how the cell lines that showed greater (or no) improvement (Figure 2) relate to the types of cancer shown in Figure 1., why is that?
Ann: Bisantrene Shows Broad Anti-Cancer Activity in Cancer Cells, page-83
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.71 |
Change
0.010(0.59%) |
Mkt cap ! $299.0M | |||
| Open | High | Low | Value | Volume |
| $1.76 | $1.79 | $1.70 | $231.1K | 131.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9724 | $1.71 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.73 | 5101 | 2 |
View Market Depth
| Last trade - 12.31pm 02/09/2024 (20 minute delay) ? |
| RAC (ASX) Chart |